Neurontin was a multi-billion dollar drug for PFE before it went generic in 2004. Thus, one would presume that the safety issue in question ought to be well characterized.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.